Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Denmark

Research and Innovation Action · Running

AIM-SAFE A Multi-Agent Framework for Safe, Specialised, and Adaptive Clinical Reasoning

Coordinator
Region Syddanmark, Denmark
Runs
1 June 2026 to 31 May 2030
Status
Running
EU funding
€16.7m
Total cost
€16.7m
Partners
26 organisations in 14 countries
Type
Research and Innovation Action
Grant agreement
101287214

What the project is doing

In the project's own words, from its summary on CORDIS.

AIM-SAFE develops a European multi-agent framework for trustworthy Generative AI in clinical decision support, tackling patient safety challenges in polypharmacy management and oncology treatment optimization. Its modular, locally deployed architecture leverages containerised SLM-powered agents that collaborate on bounded clinical functions, such as adverse drug event prediction, deprescribing support, pharmacogenomic reasoning, and phenoconversion modeling, while operating within hospital environments under robust privacy controls, continuous federated learning workflows, and explainable intelligence, fully aligned with European data governance laws (e.g., GDPR, AI Act, EHDS).

Beyond model development, AIM-SAFE equips researchers and clinicians with the knowledge, tools, and governance frameworks to apply Generative AI responsibly and effectively in practice. AIM-SAFE delivers open-source toolkits, FAIR datasets, and Safety Co-Pilot modules to advance trustworthy healthcare AI, ensuring ethics, transparency, and patient safety. Its key components include the CAFEIN federated learning platform, explainable AI engines enhanced with Reinforcement Learning from Human Feedback loops, and integrated safety governance through the RUC2 framework.

This approach enables privacy-preserving data harmonization across clinical partners, ensuring sensitive data remains under local control while contributing to shared models. The system integrates multimodal biomedical data from EHRs, pharmacogenomic profiles, imaging metadata, and European knowledge databases. By reinforcing European digital sovereignty, reducing reliance on non-EU AI providers, and ensuring full compliance with EU ethical, legal, and regulatory principles, AIM-SAFE transforms clinical decision support into a safe, explainable, and human-centred approach that reduces adverse drug events, improves patient care, and contributes to lower mortality and healthcare costs.

Topics

Who is involved

OrganisationCityCountryRole
Region SyddanmarkVejleDenmarkCoordinator
Universitat WienWienAustriaParticipant
Cancer Patients EuropeBruxelles / BrusselBelgiumParticipant
European Union Geriatric Medicine Society AisblBruxelles / BrusselBelgiumParticipant
Trinetx Europe NVSint-Martens-LatemBelgiumParticipant
Ecole Polytechnique Federale De LausanneLausanneSwitzerlandParticipant
Organisation Europeenne Pour La Recherche NucleaireGeneve 23SwitzerlandParticipant
Universite De GeneveGeneveSwitzerlandParticipant
Apheris Ai GmbHBerlinGermanyParticipant
European Molecular Biology LaboratoryHeidelbergGermanyParticipant
Ludwig-Maximilians-Universitaet MuenchenPlaneggGermanyParticipant
Technische Universitaet MuenchenMuenchenGermanyParticipant
D.tsakalidis-G.domalis OePatraGreeceParticipant
Agencia Estatal Consejo Superior De Investigaciones CientificasMadridSpainParticipant
Fedder Ai SLBarcelonaSpainThird party
Universitat De BarcelonaBarcelonaSpainParticipant
Centre Hospitalier Universitaire De ToulouseToulouse Cedex 3FranceParticipant
Agora Labs S.r.l.Collevecchio (Ri)ItalyParticipant
Korea Advanced Institute of Science and TechnologyDaejeonSouth KoreaParticipant
Academisch Ziekenhuis GroningenGroningenNetherlandsParticipant
Uniwersytet JagiellonskiKrakowPolandParticipant
leki.pl sp. z o.o.WarszawaPolandParticipant
Limited Liability Company Knowledgator EngineeringKyivUkraineParticipant
Sheffield Hallam UniversitySheffieldUnited KingdomParticipant
The Royal Marsden National Health Service TrustLondonUnited KingdomParticipant
The University of LiverpoolLiverpoolUnited KingdomParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI